Botulinum Toxin Off-Label Use in Dermatology: A Review
Open Access
- 1 February 2017
- journal article
- review article
- Published by S. Karger AG in Skin Appendage Disorders
- Vol. 3 (1), 39-56
- https://doi.org/10.1159/000452341
Abstract
Background: Botulinum toxin is a neurotoxin produced by the bacterium Clostridium botulinum which causes a flaccid muscle paralysis. It is currently used for aesthetic treatments and in the focal hyperhidrosis. Recently, botulinum toxin has also been used experimentally in many other dermatological conditions with good results. Objective: To review and analyze the possible botulinum toxin off-label applications published. Methods: A retrospective review of the published data was conducted. Conclusions: this potent drug can lead to several off-label indications of interest for dermatologists. Further clinical trials are still needed to better understand the real efficacy and safety of these applications and to standardize injection and dose protocols.Keywords
This publication has 115 references indexed in Scilit:
- Safety and Efficacy of Intradermal Injection of Botulinum Toxin for the Treatment of Oily SkinDermatologic Surgery, 2013
- Immunogenicity of botulinum toxinsJournal of Neural Transmission, 2012
- Botulinum Neurotoxin A Decreases Infiltrating Cutaneous Lymphocytes and Improves Acanthosis in the KC-Tie2 Mouse ModelJournal of Investigative Dermatology, 2012
- Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survivalJournal of the European Academy of Dermatology and Venereology, 2010
- Unilateral aquagenic keratoderma treated with botulinum toxin AJournal of Dermatological Case Reports, 2010
- Treatment of facial chromhidrosis with botulinum toxin type AJournal of the American Academy of Dermatology, 2005
- The place of botulinum toxin type A in the treatment of focal hyperhidrosisBritish Journal of Dermatology, 2004
- Local neural block at the wrist for treatment of palmar hyperhidrosis with botulinum toxin: Technical improvementsJournal of the American Academy of Dermatology, 2004
- Aluminum chloride hexahydrate and blistering in epidermolysis bullosa simplexJournal of the American Academy of Dermatology, 1990
- Treatment of recurrent bullous eruption of the hands and feet (Weber-Cockayne disease) with topical aluminum chlorideJournal of the American Academy of Dermatology, 1982